A randomized controlled trial of intranasal oxytocin in Phelan-McDermid syndrome

A randomized controlled trial of intranasal oxytocin in Phelan-McDermid syndrome

Abstract Background Phelan-McDermid syndrome (PMS) is a rare neurodevelopmental disorder caused by haploinsufficiency of the SHANK3 gene and characterized by global developmental delays, deficits in speech and motor function, and autism spectrum disorder (ASD). Monogenic causes of ASD such as PMS ar...

Full description

Bibliographic Details
Main Authors: J. Fastman, J. Foss-Feig, Y. Frank, D. Halpern, H. Harony-Nicolas, C. Layton, S. Sandin, P. Siper, L. Tang, P. Trelles, J. Zweifach, J. D. Buxbaum, A. Kolevzon
Format: Article
Language:English
Published: BMC 2021-09-01
Series:Molecular Autism
Subjects:
Phelan-McDermid syndrome
PMS
Shank3
Autism spectrum disorder
ASD
Oxytocin
Online Access:https://doi.org/10.1186/s13229-021-00459-1

Internet

https://doi.org/10.1186/s13229-021-00459-1

Similar Items